-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WErmQoEI3sr/YzAfp/U4bHnvDZ2SGKn1V1mFACVcIjWrCerzqzruylHnnJMPtRV8 BL3TteWJqZTZ37BcjI2PHQ== 0000927538-01-000001.txt : 20010223 0000927538-01-000001.hdr.sgml : 20010223 ACCESSION NUMBER: 0000927538-01-000001 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-52343 FILM NUMBER: 1541667 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MADDON PAUL J MD PH D CENTRAL INDEX KEY: 0001076491 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 SC 13G/A 1 0001.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Progenics Pharmaceuticals, Inc. ------------------------------- (Name of Issuer) Common Stock, par value $.0013 per share ---------------------------------------- (Title of Class of Securities) 743187106 --------- (CUSIP Number) December 31, 2000 ----------------- (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [x] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13G/A CUSIP No. 743187106 - --------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Paul W. Maddon, M.D., Ph.D. - --------------------------------------------------------------------------- 2 CHECK THE APPROPROPRIATE BOX IF A MEMBER OF A GROUP (a)_____ (b)_____ - --------------------------------------------------------------------------- 3 SEC USE ONLY - --------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - --------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER 630,457 OF SHARES 6 SHARED VOTING POWER BENEFICIALLY None OWNED BY EACH 7 SOLE DISPOSITIVE POWER REPORTING 630,457 PERSON WITH 8 SHARED DISPOSITIVE POWER None - --------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,630,231 - --------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) __ - --------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 12.3% - --------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON IN - --------------------------------------------------------------------------- -2- Item 1(a) Name of Issuer: Progenics Pharmaceuticals, Inc. Item 1(a) Address of Issuer's Principal Executive Offices: 777 Old Saw Mill River Road Tarrytown, New York 10591 Item 2(a) Name of Person Filing: Paul J. Maddon, M.D., Ph.D. Item 2(b) Address of Principal Business Office or, if none, Residence: 777 Old Saw Mill River Road Tarrytown, New York 10591 Item 2(c) Citizenship: United States of America Item 2(d) Title of Class of Securities: Common Stock, par value $.0013 per share Item 2(e) CUSIP Number: 743187106 Item 3. If this statement is filed pursuant to Rule 13d-1(b) or Rule 13d-2(b) or (c), check whether the person filing is a: Not applicable Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 1,630,231 shares, including 999,774 shares which the reporting person has the right to acquire within 60 days pursuant to the exercise of stock options granted by the issuer (b) Percent of class: 12.3% -3- (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 630,457 shares (ii) Shared power to vote or to direct the vote none (iii) Sole power to dispose or to direct the disposition of 630,457 shares (iv) Shared power to dispose or to direct the disposition of none Item 5. Ownership of Five Percent or Less of a Class Not applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person Not applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable Item 8. Identification and Classification of Members of the Group Not applicable Item 9. Notice of Dissolution of Group Not applicable Item 10. Certifications Not applicable SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. /s/ Paul J. Maddon --------------------------- Dated: February 12, 2001 Paul J. Maddon, M.D., Ph.D. -4- -----END PRIVACY-ENHANCED MESSAGE-----